Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial of Topical Ketotifen Fumarate 0.25% Cream for Females With Secondary Vestibulodynia

NCT07257029 is registered in ClinicalTrials.gov with Center for Vulvovaginal Disorders as lead sponsor.

NCT NCT07257029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07257029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled Trial of Topical Ketotifen Fumarate 0.25% Cream for Females With Secondary Vestibulodynia
Lead sponsor
Center for Vulvovaginal Disorders
Phase
Phase 2
Overall status
Recruiting
Start date
January 2, 2026
Completion date
January 1, 2027
Enrollment
54 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

instertional dyspareunia, mast cell-mediated neuroinflammation, neuroproliferative vestibulodynia, provoked vestibulodynia, secondary provoked vestibulodynia, vulvary pain disorders, vulvodynia